Send to

Choose Destination
Br J Hosp Med. 1993 May 19-Jun 1;49(10):710-1, 714-5.

Advanced prostate cancer: what's new in hormonal manipulation?

Author information

Department of Urology, Southmead Hospital, Bristol.


Prostate cancer is the second most common cause of male cancer deaths in the UK. It is one of the few hormone-sensitive cancers and androgen ablation produces subjective and objective tumour regression in 70-80% of patients for a variable period. Orchidectomy remains the gold standard for treatment although there is an increasing number of equally effective medical alternatives.

Comment in

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center